Innovative strategies to overcome immunotherapy resistance

The therapeutic approach of immune checkpoint inhibitors has revolutionized the long-term survival of melanoma patients, but has also reached its limits. Innovative approaches such as adoptive T-cell therapy and personalized mRNA vaccines offer new hope. In addition, the neoadjuvant paradigm has shown that the right timing of therapy can be a decisive factor.